These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4022263)

  • 1. Myoclonus in the rat induced by p,p'-DDT and the role of altered monoamine function.
    Pratt JA; Rothwell J; Jenner P; Marsden CD
    Neuropharmacology; 1985 May; 24(5):361-73. PubMed ID: 4022263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p,p'-DDT-induced myoclonus in the rat and its application as an animal model of 5-HT-sensitive action myoclonus.
    Pratt JA; Rothwell J; Jenner P; Marsden CD
    Adv Neurol; 1986; 43():577-88. PubMed ID: 2418651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimyoclonic action of clonazepam: the role of serotonin.
    Chung Hwang E; Van Woert MH
    Eur J Pharmacol; 1979 Nov; 60(1):31-40. PubMed ID: 520416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Milacemide increases 5-hydroxytryptamine and dopamine levels in rat brain--possible mechanisms of milacemide antimyoclonic property in the p,p'-DDT-induced myoclonus.
    Truong DD; Galloway MP; Pezzoli G; Jamrozik Z; Fahn S
    Pharmacol Biochem Behav; 1989 Apr; 32(4):993-1001. PubMed ID: 2572009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p,p'-DDT-induced neurotoxic syndrome: experimental myoclonus.
    Hwang EC; Van Woert MH
    Neurology; 1978 Oct; 28(10):1020-5. PubMed ID: 311446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p,p'-DDT-induced myoclonus in mice: the effect of enhanced 5-HT neurotransmission.
    Magnussen I
    Acta Pharmacol Toxicol (Copenh); 1985 Feb; 56(2):87-90. PubMed ID: 2986413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDT-induced myoclonus: serotonin and alpha noradrenergic interaction.
    Hwang EC; Van Woert MH
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):257-66. PubMed ID: 37558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p,p'-DDT-induced alterations in brain serotonin metabolism.
    Chung Hwang E; Van Woert MH
    Neurotoxicology; 1981 Dec; 2(4):649-57. PubMed ID: 6176920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT-mediated myoclonus in the guinea pig as a model of brainstem 5-HT and tryptamine receptor action.
    Luscombe G; Jenner P; Marsden CD
    Adv Neurol; 1986; 43():529-43. PubMed ID: 2418649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebellar cyclic GMP in p,p'-DDT myoclonus: effects of antimyoclonic agents.
    Chung E
    Res Commun Chem Pathol Pharmacol; 1983 Apr; 40(1):87-98. PubMed ID: 6306746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of inferior olive-climbing fibers to p,p'-DDT-induced myoclonus in rats.
    Hwang EC; Plaitakis A; Magnussen I; Van Woert MH
    Neurosci Lett; 1981 Jun; 24(1):103-8. PubMed ID: 7266934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological studies on serotonin-mediated behaviour.
    Green AR
    J Physiol (Paris); 1981; 77(2-3):437-47. PubMed ID: 6457143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p,p'-DDT myoclonic/epileptic model: serotonin receptor binding and behavioral studies in the rat.
    Pranzatelli MR; Tailor PT; Pluchino R; Gonzales W; Simmens S
    Neurotoxicology; 1994; 15(2):261-72. PubMed ID: 7991214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tryptamine-induced myoclonus in guinea-pigs pretreated with a monoamine oxidase inhibitor indicates pre- and post-synaptic actions of tryptamine upon central indoleamine systems.
    Luscombe G; Jenner P; Marsden CD
    Neuropharmacology; 1982 Dec; 21(12):1257-65. PubMed ID: 6130489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimyoclonic properties of S2 serotonin receptor antagonists in the rat.
    Pranzatelli MR; Snodgrass SR
    Neuropharmacology; 1986 Jan; 25(1):5-12. PubMed ID: 2936977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of prostaglandins in the antimyoclonic action of clonazepam.
    Hwang EC; Van Woert MH
    Eur J Pharmacol; 1981 Apr; 71(1):161-4. PubMed ID: 7238584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional glycine receptor binding in the p,p'-DDT myoclonic rat model.
    Pranzatelli MR; Tkach K
    Arch Toxicol; 1992; 66(1):73-6. PubMed ID: 1316118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDT myoclonus: sites and mechanism of action.
    Chung E; Van Woert MH
    Exp Neurol; 1984 Aug; 85(2):273-82. PubMed ID: 6378651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of p,p'-DDT-induced tremor by catecholaminergic agents.
    Herr DW; Tilson HA
    Toxicol Appl Pharmacol; 1987 Nov; 91(2):149-58. PubMed ID: 3672520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.